Daidzein from Dietary Supplement to a Drug Candidate: An Evaluation of Potential.

Our assessment

This analysis, published in 2023, is a scientific review of the compound daidzein, an isoflavone found in foods like soybeans, alfalfa, and red clover. The study evaluates daidzein's potential to move from being a dietary supplement to a drug candidate. As a review article, it summarizes existing research rather than conducting a new experiment on a specific group of participants. The authors note that daidzein's structure and function are similar to human estrogens NIH ODS ↗.

How it works

Think of daidzein as a plant-based compound that can mimic some actions of estrogen in your body. The review reports that daidzein has demonstrated a broad range of potential beneficial effects, including supporting cardiovascular exercise, reducing cholesterol, and showing anticancer, antifibrotic, and antidiabetic properties. What this means for you is that daidzein, found in common foods like soy, is being studied for its potential to help manage or prevent several chronic conditions due to its estrogen-like activity NIH ODS ↗.

Safety profile

Data not available. The provided study does not include specific adverse event report counts from FDA data or detailed side effect information for daidzein. General safety information for isoflavone supplements is available from other sources, but specific data for this compound is not included here FDA FAERS ↗.

Our recommendation

Daidzein is a naturally occurring compound in soy-based foods, which are generally considered safe as part of a balanced diet. Because this is a review of its drug potential, specific dosing recommendations are not provided. If you are considering daidzein supplements, it is best to consult with a healthcare provider, especially given its estrogen-like effects, which may not be appropriate for everyone. More targeted clinical studies are needed to confirm its benefits and establish safe dosages NIH ODS ↗.